• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与血液透析患者相比,持续性非卧床腹膜透析患者骨矿物质密度的鉴定。

The identification of bone mineral density in CAPD in comparison with HD patients.

作者信息

Pasadakis P, Thodis E, Manavis J, Mourvati E, Panagoutsos S, Vargemezis V

机构信息

Democritus University of Thrace, Division of Nephrology, General District Hospital, Alexadroupolis, Greece.

出版信息

Adv Perit Dial. 1995;11:247-53.

PMID:8534716
Abstract

Renal osteodystrophy is a virtually universal complication of chronic renal failure (CRF). Varying degrees of calcium-phosphate metabolism derangement and different types of skeletal damage are observed in CRF for many reasons while the use of dialysis for the management of end-stage renal failure further affects these complications. This study was designed to evaluate the bone mineral density (BMD) that is measured by dual-energy x-ray in three groups of patients: A, 10 patients on continuous ambulatory peritoneal dialysis (CAPD); B, 10 patients on hemodialysis (HD); and C, 10 predialytic patients with advanced CRF. All patients were matched for age, sex, duration of dialysis (> 3 years), and the use of phosphate binders. Biochemical (serum iPTH levels, SAP, Ca, P) and radiological bone studies were compared in the three groups. The majority of predialytic patients had BMD values within the normal range, while the BMD values in PD patients were higher (0.985 g/cm2) in comparison with HD patients (0.949 g/cm2). Some patients, especially in the HD population, showed an increase in BMD with time on dialysis. From all other comparisons, radiological signs of high turnover bone disease and osteopenia were the only variables that were correlated with BMD. All these findings suggest that dialysis affects the bone status and that CAPD patients have better bone mineral metabolism as shown mainly with the use of BMD measurements.

摘要

肾性骨营养不良实际上是慢性肾衰竭(CRF)的一种普遍并发症。由于多种原因,在CRF患者中可观察到不同程度的钙磷代谢紊乱和不同类型的骨骼损害,而使用透析治疗终末期肾衰竭会进一步影响这些并发症。本研究旨在评估三组患者通过双能X线测量的骨密度(BMD):A组,10例持续非卧床腹膜透析(CAPD)患者;B组,10例血液透析(HD)患者;C组,10例晚期CRF的透析前患者。所有患者在年龄、性别、透析时间(>3年)和使用磷结合剂方面进行了匹配。比较了三组患者的生化指标(血清iPTH水平、SAP、钙、磷)和放射学骨研究结果。大多数透析前患者的BMD值在正常范围内,而与HD患者(0.949g/cm²)相比,PD患者的BMD值更高(0.985g/cm²)。一些患者,尤其是HD组的患者,随着透析时间的延长BMD有所增加。在所有其他比较中,高转换骨病和骨质减少的放射学征象是与BMD相关的唯一变量。所有这些发现表明透析会影响骨状态,并且CAPD患者具有更好的骨矿物质代谢,这主要通过BMD测量得以体现。

相似文献

1
The identification of bone mineral density in CAPD in comparison with HD patients.与血液透析患者相比,持续性非卧床腹膜透析患者骨矿物质密度的鉴定。
Adv Perit Dial. 1995;11:247-53.
2
[Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].通过三点骨密度测定法评估透析患者的肾性骨营养不良
Przegl Lek. 2000;57(6):334-9.
3
Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.持续非卧床腹膜透析患者皮质骨矿物质密度保持的证据。
J Bone Miner Res. 1996 Jan;11(1):96-104. doi: 10.1002/jbmr.5650110114.
4
Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry.采用双能X线吸收法评估持续性非卧床腹膜透析患者的骨矿物质密度。
Adv Perit Dial. 1996;12:245-9.
5
Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.血液透析和持续性非卧床腹膜透析患者骨转换体液标志物与骨密度的比较。
Nephron. 2002 May;91(1):94-102. doi: 10.1159/000057610.
6
Renal osteodystrophy in Ramathibodi Hospital: histomorphometry and clinical correlation.拉玛蒂博迪医院的肾性骨营养不良:组织形态计量学与临床相关性
J Med Assoc Thai. 2000 Oct;83(10):1223-32.
7
The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients.双能X线骨密度测定法在评估持续性非卧床腹膜透析患者肾性骨营养不良中的作用。
Perit Dial Int. 1996 Jan-Feb;16(1):34-40.
8
Skeletal status in children, adolescents and young adults with end-stage renal failure treated with hemo- or peritoneal dialysis.
Osteoporos Int. 2002 May;13(5):353-7. doi: 10.1007/s001980200039.
9
[Bone metabolism in dialysis patient assessed by biochemical markers and densitometry].[通过生化标志物和骨密度测定评估透析患者的骨代谢]
Pol Arch Med Wewn. 2003 Sep;110(3):967-72.
10
Bone mineral density among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).接受持续性非卧床腹膜透析(CAPD)的患者的骨矿物质密度
J Med Assoc Thai. 2005 Oct;88 Suppl 5:S40-5.

引用本文的文献

1
FGF-23, α-Klotho Gene Polymorphism and Their Relationship with the Markers of Bone Metabolism in Chronic Peritoneal Dialysis Patients.成纤维细胞生长因子-23、α-klotho基因多态性及其与慢性腹膜透析患者骨代谢标志物的关系
Eurasian J Med. 2015 Jun;47(2):115-25. doi: 10.5152/eurasianjmed.2015.93.
2
Bone mineral density in patients on maintenance dialysis.维持性透析患者的骨矿物质密度。
Int Urol Nephrol. 2010 Sep;42(3):723-39. doi: 10.1007/s11255-009-9666-2. Epub 2009 Dec 29.
3
Osteoporosis in the elderly with chronic kidney disease.老年慢性肾脏病患者的骨质疏松症
Int Urol Nephrol. 2007;39(1):321-31. doi: 10.1007/s11255-006-9109-2. Epub 2006 Nov 11.
4
Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.慢性腹膜透析患者的骨矿物质密度及其与临床和实验室因素的相关性。
J Bone Miner Metab. 2006;24(1):79-86. doi: 10.1007/s00774-005-0650-3.
5
Bone density measurements in pediatric patients with renal osteodystrophy.患有肾性骨营养不良的儿科患者的骨密度测量
Pediatr Nephrol. 2003 Jun;18(6):554-9. doi: 10.1007/s00467-002-1041-9. Epub 2003 Apr 24.